Surgical removal of the index node marked using magnetic seed localization to assess response to neoadjuvant immunotherapy in patients with stage III melanoma

This pilot study explored the value of localized index node removal after neoadjuvant immunotherapy in patients with stage III melanoma, for use as a response indicator to guide the extent of completion lymph node dissection. [Image: see text] Promising technology

Detalles Bibliográficos
Autores principales: Schermers, B., Franke, V., Rozeman, E. A., van de Wiel, B. A., Bruining, A., Wouters, M. W., van Houdt, W. J., ten Haken, B., Muller, S. H., Bierman, C., Ruers, T. J. M., Blank, C. U., van Akkooi, A. C. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd. 2019
Materias:
Rapid Research Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593699/
https://www.ncbi.nlm.nih.gov/pubmed/30882901
http://dx.doi.org/10.1002/bjs.11168
Descripción
Sumario:This pilot study explored the value of localized index node removal after neoadjuvant immunotherapy in patients with stage III melanoma, for use as a response indicator to guide the extent of completion lymph node dissection. [Image: see text] Promising technology

Ejemplares similares